{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:23:18Z","timestamp":1785154998316,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010315","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:00:00Z","timestamp":1507680000000}}],"reference-count":93,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010315.pub2","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T16:23:53Z","timestamp":1507739033000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Blood pressure targets for the treatment of people with hypertension and cardiovascular disease"],"prefix":"10.1002","author":[{"given":"Luis Carlos","family":"Saiz","sequence":"first","affiliation":[{"name":"Navarre Health Service; Drug Prescribing Service; Plaza de la Paz, s\/n, 7th floor Pamplona Navarre Spain 31002"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gorricho","sequence":"additional","affiliation":[{"name":"Navarre Health Service; Drug Prescribing Service; Plaza de la Paz, s\/n, 7th floor Pamplona Navarre Spain 31002"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garj\u00f3n","sequence":"additional","affiliation":[{"name":"Navarre Health Service; Drug Prescribing Service; Plaza de la Paz, s\/n, 7th floor Pamplona Navarre Spain 31002"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa Concepci\u00f3n","family":"Celaya","sequence":"additional","affiliation":[{"name":"Navarre Health Service; Drug Prescribing Service; Plaza de la Paz, s\/n, 7th floor Pamplona Navarre Spain 31002"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Muruz\u00e1bal","sequence":"additional","affiliation":[{"name":"Navarre Health Service; Drug Prescribing Service; Plaza de la Paz, s\/n, 7th floor Pamplona Navarre Spain 31002"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa del Mar","family":"Mal\u00f3n","sequence":"additional","affiliation":[{"name":"Navarre Health Service; Centro de Salud de Olite; Alcalde de Maillata, 9 Olite Navarra Spain 31390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Montoya","sequence":"additional","affiliation":[{"name":"Navarre Health Service; Primary Care; C\/ Mayor, S\/N Anc\u00edn Navarra Spain 31281"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Navarre Health Service; Drug Prescribing Service; Plaza de la Paz, s\/n, 7th floor Pamplona Navarre Spain 31002"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"key":"10.1002\/14651858.CD010315.pub2-BIB0002|cit1","doi-asserted-by":"crossref","unstructured":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial-correction JAMA 2006 2726 10.1001\/jama.295.23.2726-c","DOI":"10.1001\/jama.295.23.2726-c"},{"issue":"7 Suppl 2","key":"10.1002\/14651858.CD010315.pub2-BIB0001|cit2","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1097\/01.ASN.0000070081.15137.C0","article-title":"The rationale and design of the AASK cohort study","volume":"14","author":"Appel","year":"2003","journal-title":"Journal of the American Society of Nephrology : JASN"},{"issue":"7 Suppl 2","key":"10.1002\/14651858.CD010315.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1097\/01.ASN.0000070080.21680.CB","article-title":"Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK)","volume":"14","author":"Gassman","year":"2003","journal-title":"Journal of the American Society of Nephrology : JASN"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1053\/j.ajkd.2006.08.004","article-title":"Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial","volume":"48","author":"Norris","year":"2006","journal-title":"American Journal of Kidney Diseases"},{"issue":"19","key":"10.1002\/14651858.CD010315.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"17","key":"10.1002\/14651858.CD010315.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Evans","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"12A","key":"10.1002\/14651858.CD010315.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","article-title":"Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods","volume":"99","author":"Buse","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"12A","key":"10.1002\/14651858.CD010315.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"44i","DOI":"10.1016\/j.amjcard.2007.03.005","article-title":"Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"99","author":"Cushman","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub2-BIB0010|cit9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3109\/08037059409102281","article-title":"The Hypertension Optimal Treatment (HOT) Study - patient characteristics: randomization, risk profiles, and early blood pressure results","volume":"3","author":"Hansson","year":"1994","journal-title":"Blood Pressure"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub2-BIB0011|cit10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/08037059709062088","article-title":"The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability","volume":"6","author":"Hansson","year":"1997","journal-title":"Blood Pressure"},{"issue":"9118","key":"10.1002\/14651858.CD010315.pub2-BIB0009|cit11","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD010315.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/08037059309077529","article-title":"The Hypertension Optimal Treatment Study (the HOT Study)","volume":"2","author":"Hansson","year":"1993","journal-title":"Blood Pressure"},{"issue":"4","key":"10.1002\/14651858.CD010315.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/01.hjh.0000052482.18130.b2","article-title":"Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?","volume":"21","author":"Zanchetti","year":"2003","journal-title":"Journal of Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD010315.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00004872-200106000-00021","article-title":"Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group","volume":"19","author":"Zanchetti","year":"2001","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2261-10-37","article-title":"Protocol for Past BP: a randomised controlled trial of different blood pressure targets for people with a history of stroke of transient ischaemic attack (TIA) in primary care","volume":"10","author":"Fletcher","year":"2010","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0016|cit16","first-page":"627","article-title":"RCT of different systolic blood pressure targets for people with a history or stroke or transient ischaemic attack: the PAST-BP (Prevention After Stroke - Blood Pressure) study","volume":"28","author":"Mant","year":"2014","journal-title":"Journal of Human Hypertension"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"i708","DOI":"10.1136\/bmj.i708","article-title":"Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke-Blood Pressure) randomised controlled trial","volume":"352","author":"Mant","year":"2016","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clinical Trials (London, England)"},{"issue":"22","key":"10.1002\/14651858.CD010315.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Williamson","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"24","key":"10.1002\/14651858.CD010315.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: a randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD010315.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1747-4949.2010.00573.x","article-title":"The Secondary Prevention of Small Subcortical Strokes (SPS3) study","volume":"6","author":"Benavente","year":"2011","journal-title":"International Journal of Stroke"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1177\/1740774516643689","article-title":"A post hoc evaluation of a sample size re-estimation in the Secondary Prevention of Small Subcortical Strokes study","volume":"13","author":"McClure","year":"2016","journal-title":"Clinical Trials (London, England)"},{"issue":"9891","key":"10.1002\/14651858.CD010315.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"Coffey","year":"2013","journal-title":"Lancet"},{"issue":"13","key":"10.1002\/14651858.CD010315.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group","volume":"330","author":"Klahr","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0025|cit25","unstructured":"NCT01230216 Effect of intensive blood pressure control on progression of coronary atherosclerosis: randomized evaluation by intravascular ultrasound clinicaltrials.gov\/ct2\/show\/NCT01230216"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1745-6215-14-401","article-title":"Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids","volume":"14","author":"Blackburn","year":"2013","journal-title":"Trials"},{"issue":"9463","key":"10.1002\/14651858.CD010315.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010315.pub2-BIB0028|cit28","first-page":"39","article-title":"Rationale of the REstart or STop Antithrombotics Randomised Trial in Asia Pacific (RESTART-AP)","volume":"36","author":"Arima","year":"2013","journal-title":"Cerebrovascular Diseases"},{"issue":"10","key":"10.1002\/14651858.CD010315.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199803053381003","article-title":"The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension","volume":"338","author":"Estacio","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010315.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0197-2456(95)00154-9","article-title":"Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial","volume":"17","author":"Estacio","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"-","key":"10.1002\/14651858.CD010315.pub2-BIB0031|cit31","article-title":"The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes","volume":"104","author":"Savage","year":"1993","journal-title":"Online Journal of Current Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD010315.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/08037059409102265","article-title":"The BBB Study: the effect of intensified antihypertensive treatment on the level of blood pressure, side-effects, morbidity and mortality in \"well-treated\" hypertensive patients. Behandla Blodtryck Battre","volume":"3","author":"Hannson","year":"1994","journal-title":"Blood Pressure"},{"issue":"9","key":"10.1002\/14651858.CD010315.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00004872-198809000-00002","article-title":"The BBB study: a prospective randomized study of intensified antihypertensive treatment.","volume":"6","author":"The BBB study group","year":"1988","journal-title":"Journal of Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD010315.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/sj.jhh.1002313","article-title":"Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population","volume":"22","author":"Staessen","year":"2008","journal-title":"Journal of Human Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD010315.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1161\/HYPERTENSIONAHA.113.02089","article-title":"\ufeffTight versus standard blood pressure control in patients with hypertension with and without cardiovascular disease","volume":"63","author":"Reboldi","year":"2014","journal-title":"Hypertension"},{"issue":"9689","key":"10.1002\/14651858.CD010315.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0140-6736(09)61340-4","article-title":"Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial","volume":"374","author":"Verdecchia","year":"2009","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD010315.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1097\/HJH.0000000000000254","article-title":"Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial","volume":"32","author":"Zanchetti","year":"2014","journal-title":"Journal of Hypertension"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD010315.pub2-BIB0039|cit38","first-page":"465","article-title":"HOSP study","volume":"64","author":"Kawano","year":"2006","journal-title":"Nihon Rinsho. Japanese Journal of Clinical Medicine"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD010315.pub2-BIB0038|cit39","first-page":"329","article-title":"Hypertension control based on home systolic pressure (HOSP) study: Design and interim report of the main study","volume":"20","author":"Kawano","year":"2006","journal-title":"Journal of Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD010315.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ahj.2012.11.008","article-title":"INtensive versus standard ambulatory blood pressure lowering to prevent functional DeclINe in the ElderlY (INFINITY)","volume":"165","author":"White","year":"2013","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0041|cit41","unstructured":"ISRCTN37694103 How intensively should we treat blood PRESsure in established cERebral small VEssel disease? www.isrctn.com\/ISRCTN37694103"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0042|cit42","unstructured":"NCT01198496 Recurrent stroke prevention clinical outcome study (RESPECTS) clinicaltrials.gov\/ct2\/show\/NCT01198496"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0043|cit43","unstructured":"NCT03015311 Strategy of blood pressure intervention in the elderly hypertensive patients (STEP) clinicaltrials.gov\/ct2\/show\/NCT03015311"},{"issue":"21","key":"10.1002\/14651858.CD010315.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1161\/circulationaha.107.183885","article-title":"Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Council on Clinical Cardiology and Epidemiology and Prevention","volume":"115","author":"Rosendorff","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD010315.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004349.pub2","article-title":"Treatment blood pressure targets for hypertension","author":"Arguedas","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010315.pub2-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008277.pub2","article-title":"Blood pressure targets for hypertension in people with diabetes mellitus","author":"Arguedas","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"23","key":"10.1002\/14651858.CD010315.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1093\/eurheartj\/ehq328","article-title":"J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial","volume":"31","author":"Bangalore","year":"2010","journal-title":"European Heart Journal"},{"issue":"24","key":"10.1002\/14651858.CD010315.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood pressure targets in subjects with type 2 diabetes mellitus\/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials","volume":"123","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"issue":"9","key":"10.1002\/14651858.CD010315.pub2-BIB0049|cit49","first-page":"601","article-title":"Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials","volume":"99","author":"Bangalore","year":"2013","journal-title":"Heart (British Cardiac Society)"},{"issue":"6","key":"10.1002\/14651858.CD010315.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.amjmed.2017.01.004","article-title":"Optimal systolic blood pressure target after SPRINT: insights from a network meta-analysis of randomized trials","volume":"130","author":"Bangalore","year":"2017","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"f5680","DOI":"10.1136\/bmj.f5680","article-title":"Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials","volume":"347","author":"Perkovic","year":"2013","journal-title":"BMJ"},{"issue":"9943","key":"10.1002\/14651858.CD010315.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2014","journal-title":"Lancet"},{"issue":"10017","key":"10.1002\/14651858.CD010315.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0140-6736(15)00816-8","article-title":"Lower blood pressure targets: to whom do they apply?","volume":"387","author":"Brunstr\u00f6m","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cjca.2015.02.016","article-title":"The 2015 Canadian Hypertension Education Program. Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension","volume":"31","author":"Daskalopoulou","year":"2015","journal-title":"Canadian Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cjca.2016.02.066","article-title":"Hypertension Canada\u2019s 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension","volume":"32","author":"Leung","year":"2016","journal-title":"Canadian Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD010315.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/CIR.0b013e31821d9ef2","article-title":"ACCF\/AHA\/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement","volume":"124","author":"Drozda","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD010315.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/hjh.0b013e328333146d","article-title":"Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document","volume":"18","author":"Mancia","year":"2009","journal-title":"Journal of Hypertension"},{"issue":"12","key":"10.1002\/14651858.CD010315.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/eurheartj\/ehm236","article-title":"2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"28","author":"Mancia","year":"2007","journal-title":"European Heart Journal"},{"issue":"28","key":"10.1002\/14651858.CD010315.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"European Heart Journal"},{"issue":"10022","key":"10.1002\/14651858.CD010315.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD010315.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.1991.03460040065031","article-title":"The J-Curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?","volume":"265","author":"Farnett","year":"1991","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD010315.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jash.2014.05.002","article-title":"Lowering blood pressure to prevent stroke recurrence: a systematic review of long-term randomized trials","volume":"8","author":"Feldstein","year":"2014","journal-title":"Journal of the American Society of Hypertension : JASH"},{"issue":"2","key":"10.1002\/14651858.CD010315.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3949\/ccjm.78a.10101","article-title":"Goal-directed antihypertensive therapy: Lower may not always be better","volume":"78","author":"Fillippone","year":"2011","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"10010","key":"10.1002\/14651858.CD010315.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Forouzanfar","year":"2015","journal-title":"Lancet"},{"issue":"9963","key":"10.1002\/14651858.CD010315.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"GBD 2013 Mortality and Causes of Death Collaborators","year":"2015","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0066|cit66","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0067|cit67","unstructured":"European Medicines Agency Clinical Safety Data Management: Definitions and Standards for Expedited Reporting.(CPMP\/ICH\/377\/95). 1995 www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500002749.pdf"},{"issue":"19","key":"10.1002\/14651858.CD010315.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD010315.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"29","key":"10.1002\/14651858.CD010315.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehs092","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD010315.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"9362","key":"10.1002\/14651858.CD010315.pub2-BIB0072|cit72","first-page":"1903","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD010315.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"e1001293","DOI":"10.1371\/journal.pmed.1001293","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis","volume":"9","author":"Lv","year":"2012","journal-title":"PLoS Medicine"},{"issue":"11","key":"10.1002\/14651858.CD010315.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1503\/cmaj.121468","article-title":"Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"185","author":"Lv","year":"2013","journal-title":"CMAJ : Canadian Medical Association Journal"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010315.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.2337\/dc11-s244","article-title":"Antihypertensive treatment and blood pressure in diabetic and nondiabetic patients: the lower, the better?","volume":"34","author":"Mancia","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD010315.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/HYPERTENSIONAHA.113.01922","article-title":"Aggressive blood pressure lowering is dangerous: the J-curve: pro side of the arguement","volume":"63","author":"Mancia","year":"2014","journal-title":"Hypertension"},{"issue":"17","key":"10.1002\/14651858.CD010315.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archinternmed.2012.3147","article-title":"Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis","volume":"172","author":"McBrien","year":"2012","journal-title":"Archives of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD010315.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","article-title":"Dogma disputed: can aggressively lowering pressure in hypertensive patients with coronary artery disease be dangerous?","volume":"144","author":"Messerli","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010315.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics - 2015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0080|cit80","unstructured":"National Clinical Guideline Centre Hypertension: clinical management of primary hypertension in adults Hypertension: the clinical management of primary hypertension in adults. CG127"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0081|cit81","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"4","key":"10.1002\/14651858.CD010315.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/HCO.0b013e32832bfb48","article-title":"Evidence for a lower target blood pressure for people with heart disease","volume":"24","author":"Rosendorff","year":"2009","journal-title":"Current Opinion in Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD010315.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/HYP.0000000000000018","article-title":"Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"65","author":"Rosendorff","year":"2015","journal-title":"Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD010315.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11883-010-0094-7","article-title":"Evidence for aggressive blood pressure-lowering goals in patients with coronary artery disease","volume":"12","author":"Roy","year":"2010","journal-title":"Current Atherosclerosis Reports"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0085|cit85","unstructured":"SBU Moderately elevated blood pressure. A systematic literature review. Swedish Council on Health Technology Assessment in Health Care (SBU); 2007. SBU report no 170 www.sbu.se\/en\/publications\/sbu-assesses\/moderately-elevated-blood-pressure\/"},{"issue":"42","key":"10.1002\/14651858.CD010315.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"European Heart Journal"},{"issue":"8","key":"10.1002\/14651858.CD010315.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"541","DOI":"10.7326\/0003-4819-154-8-201104190-00335","article-title":"Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier","volume":"154","author":"Upadhyay","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010315.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/HYPERTENSIONAHA.113.01018","article-title":"Aggressive blood pressure lowering is dangerous: the J-curve: con side of the arguement","volume":"63","author":"Verdecchia","year":"2014","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1161\/HYPERTENSIONAHA.116.07608","article-title":"More Versus Less Intensive Blood Pressure-Lowering Strategy. Cumulative Evidence and Trial Sequential Analysis","volume":"68","author":"Verdecchia","year":"2016","journal-title":"Hypertension"},{"issue":"10056","key":"10.1002\/14651858.CD010315.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(16)31326-5","article-title":"Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study","volume":"388","author":"Vidal-Petiot","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010315.pub2-BIB0091|cit91","unstructured":"World Health Organization Global status report on noncommunicable diseases 2010. Description of the global burden of NCDs, their risk factors and determinants www.who.int\/nmh\/publications\/ncd_report2010\/en\/"},{"issue":"10017","key":"10.1002\/14651858.CD010315.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD010315.pub2-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010315","article-title":"Blood pressure targets for the treatment of patients with hypertension and cardiovascular disease","author":"Gorricho","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd010315.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010315.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:42:43Z","timestamp":1628548963000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD010315.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,11]]},"references-count":93,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010315.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD010315.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,11]]}}}